Roy I, Smilnak G, Burkart M, Hamilton E, et al. Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Br J Haematol 2022 Feb 9. doi: 10.1111/bjh.18054.
PMID: 35141891